Sun Pharmaceutical (India) Probability of Future Stock Price Finishing Over 1537.56

SUNPHARMA   1,781  46.65  2.69%   
Sun Pharmaceutical's future price is the expected price of Sun Pharmaceutical instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Sun Pharmaceutical Industries performance during a given time horizon utilizing its historical volatility. Check out Sun Pharmaceutical Backtesting, Sun Pharmaceutical Valuation, Sun Pharmaceutical Correlation, Sun Pharmaceutical Hype Analysis, Sun Pharmaceutical Volatility, Sun Pharmaceutical History as well as Sun Pharmaceutical Performance.
  
Please specify Sun Pharmaceutical's target price for which you would like Sun Pharmaceutical odds to be computed.

Sun Pharmaceutical Target Price Odds to finish over 1537.56

The tendency of Sun Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay above  1,538  in 90 days
 1,781 90 days 1,538 
close to 99
Based on a normal probability distribution, the odds of Sun Pharmaceutical to stay above  1,538  in 90 days from now is close to 99 (This Sun Pharmaceutical Industries probability density function shows the probability of Sun Stock to fall within a particular range of prices over 90 days) . Probability of Sun Pharmaceutical price to stay between  1,538  and its current price of 1780.9 at the end of the 90-day period is about 10.61 .
Assuming the 90 days trading horizon Sun Pharmaceutical Industries has a beta of -0.17. This usually implies as returns on the benchmark increase, returns on holding Sun Pharmaceutical are expected to decrease at a much lower rate. During a bear market, however, Sun Pharmaceutical Industries is likely to outperform the market. Additionally Sun Pharmaceutical Industries has an alpha of 0.0107, implying that it can generate a 0.0107 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Sun Pharmaceutical Price Density   
       Price  

Predictive Modules for Sun Pharmaceutical

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sun Pharmaceutical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
1,7791,7801,782
Details
Intrinsic
Valuation
LowRealHigh
1,5201,5211,959
Details
Naive
Forecast
LowNextHigh
1,7731,7741,776
Details
Earnings
Estimates (0)
LowProjected EPSHigh
10.4011.3011.97
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Sun Pharmaceutical. Your research has to be compared to or analyzed against Sun Pharmaceutical's peers to derive any actionable benefits. When done correctly, Sun Pharmaceutical's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Sun Pharmaceutical.

Sun Pharmaceutical Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Sun Pharmaceutical is not an exception. The market had few large corrections towards the Sun Pharmaceutical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Sun Pharmaceutical Industries, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Sun Pharmaceutical within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.01
β
Beta against Dow Jones-0.17
σ
Overall volatility
51.47
Ir
Information ratio -0.12

Sun Pharmaceutical Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Sun Pharmaceutical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Sun Pharmaceutical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Sun Pharmaceutical generated a negative expected return over the last 90 days
Sun Pharmaceutical is unlikely to experience financial distress in the next 2 years
About 55.0% of the company outstanding shares are owned by corporate insiders
Latest headline from news.google.com: Volumes jump at Sun Pharma Advanced Research Company Ltd counter - Business Standard

Sun Pharmaceutical Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Sun Stock often depends not only on the future outlook of the current and potential Sun Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sun Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding2.4 B
Cash And Short Term Investments193.3 B

Sun Pharmaceutical Technical Analysis

Sun Pharmaceutical's future price can be derived by breaking down and analyzing its technical indicators over time. Sun Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Sun Pharmaceutical Industries. In general, you should focus on analyzing Sun Stock price patterns and their correlations with different microeconomic environments and drivers.

Sun Pharmaceutical Predictive Forecast Models

Sun Pharmaceutical's time-series forecasting models is one of many Sun Pharmaceutical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Sun Pharmaceutical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Sun Pharmaceutical

Checking the ongoing alerts about Sun Pharmaceutical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Sun Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Sun Pharmaceutical generated a negative expected return over the last 90 days
Sun Pharmaceutical is unlikely to experience financial distress in the next 2 years
About 55.0% of the company outstanding shares are owned by corporate insiders
Latest headline from news.google.com: Volumes jump at Sun Pharma Advanced Research Company Ltd counter - Business Standard

Additional Tools for Sun Stock Analysis

When running Sun Pharmaceutical's price analysis, check to measure Sun Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sun Pharmaceutical is operating at the current time. Most of Sun Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Sun Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sun Pharmaceutical's price. Additionally, you may evaluate how the addition of Sun Pharmaceutical to your portfolios can decrease your overall portfolio volatility.